Clinical Assessment of Spasticity in People With Spinal Cord Damage: Recommendations From the Ability Network, an International Initiative

Nene, A.V.; Campos, Alexandre Rainha; Grabljevec, Klemen; Lopes, Arminda; Skoog, Bengt; Burns, Anthony S.

doi:10.1016/j.apmr.2018.01.018

Cited by 17 publications

(18 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The objective of the assessment was to measure all the types of repercussions that spasticity can have on the SCI patient to decide which is the best treatment and check whether each complication has improved or remitted after our intervention [ 46 , 69 ].…”

Section: Treatment Of Spasticity In Spinal Cord Injury With Botulinum Toxinmentioning

confidence: 99%

Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury

Palazón-García

Benavente-Valdepeñas

2021

IJMS

View full text Add to dashboard Cite

Botulism has been known for about three centuries, and since its discovery, botulinum toxin has been considered one of the most powerful toxins. However, throughout the 20th century, several medical applications have been discovered, among which the treatment of spasticity stands out. Botulinum toxin is the only pharmacological treatment recommended for spasticity of strokes and cerebral palsy. Although its use as an adjuvant treatment against spasticity in spinal cord injuries is not even approved, botulinum toxin is being used against such injuries. This article describes the advances that have been made throughout history leading to the therapeutic use of botulinum toxin and, in particular, its application to the treatment of spasticity in spinal cord injury.

show abstract

Section: Treatment Of Spasticity In Spinal Cord Injury With Botulinum Toxinmentioning

confidence: 99%

Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury

Palazón-García

Benavente-Valdepeñas

2021

IJMS

View full text Add to dashboard Cite

show abstract

“…Time efficiency is also a factor to be considered, as measuring must be practicable both for the patient and the team. There are a few recent publications reviewing different instruments used in evaluation of spasticity [60,61]. In 2015, the Ability Network did a thorough inventory on the instruments being used in spasticity research, where the instruments related to SCI has been published [60].…”

Section: Assessment and Outcome Measurementsmentioning

confidence: 99%

“…Further information can be found in appendix 1 (table 1). In the paper by Nene et al [60] and at https://www.sralab.org/rehabilitation-measures, some of these instruments are evaluated regarding their usefulness and psychometric properties.…”

Section: Measuring Body Function and Structuresmentioning

confidence: 99%

See 1 more Smart Citation

Studies on Spasticity from an Interventional Perspective

Ertzgaard

2018

Linköping University Medical Dissertations

View full text Add to dashboard Cite

This thesis focuses on interventional aspects of spasticity, but has a very holistic approach, grounded in the specialty of Rehabilitation medicine. This means capturing the effects of spasticity, on such a complex biological system as the human being, living in a psychosocial context affecting the situation. When evaluating spasticity there are a number of levels of evidence. The first of course, understanding what we mean with spasticity, where there unfortunately is no consensus. The second level is to study if our treatments affect spasticity in a positive direction. The third is to grasp if a decrease in spasticity improve or normalize patient's movement patterns. The fourth level investigates if improvement in movement patterns improve patient's ability to perform activities; and the fifth level, comprising whether this intervention improves life satisfaction. Finally, on a societal level, we wish to investigate whether the improvement in life satisfaction or health related quality of life would motivate society to fund the intervention. Paper I on Goal Attainment Scaling pointed out necessary aspects to consider when using this instrument. This relates, among other things, to the need of learning ("the art of") goal setting and deciding the purpose of the measurements. Research and clinical use puts different demands on the instrument, for the latter time-efficiency and simplicity to use being most important. For research, it is important to be able to register deterioration, and this can be achieved using the 6-step version.

show abstract

“…A wide range of clinical and functional measures have been utilized to assess spasticity in individuals with SCD. The utilization of these measures in clinical practice has recently been discussed by Nene et al 9 To fully capture the impact of spasticity on the individual, it is increasingly recognized that patient-reported outcome measures (PROMs), particularly measures of HRQoL, are an important complement to clinical and functional measures. In addition, disabling spasticity can increase the burden on caregivers and adversely impact their wellbeing; therefore there is also value in capturing this aspect of spasticity.…”

Section: Introductionmentioning

confidence: 99%

A review and evaluation of patient-reported outcome measures for spasticity in persons with spinal cord damage: Recommendations from the Ability Network – an international initiative

Ertzgaard

Nene

Kiekens

et al. 2019

The Journal of Spinal Cord Medicine

Self Cite

View full text Add to dashboard Cite

Context: Patient-reported outcome measures (PROMs) are valuable for capturing the impact of spasticity on health-related quality of life (HRQoL) in persons with spinal cord damage (SCD) and evaluating the efficacy of interventions. Objective: To provide practical guidance for measuring HRQoL in persons with spasticity following SCD. Methods: Literature reviews identified measures of HRQoL and caregiver burden, utilized in studies addressing spasticity in SCD. Identified measures were evaluated for clinical relevance and practicality for use in clinical practice and research. The PRISM, SCI-SET, EQ-5D and SF-36 instruments were mapped to the International Classification of Functioning, Disability and Health (ICF). The PRISM and SCI-SET were evaluated using the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) checklist. Results: Two spasticity-specific, five generic, and four preference-based measures were identified. ICF mapping and the COSMIN checklist supported the use of the PRISM and SCI-SET in SCD. The SF-36 is considered the most useful generic measure; disability-adapted versions may be more acceptable but further studies on psychometric properties are required. The SF-36 can be converted to a preference-based measure (SF-6D), or alternatively the EQ-5D can be used. While no measures specific to caregivers of people with SCD were identified, the Caregiver Burden Scale and the Zarit Burden Interview are considered suitable. Conclusion: Recommended measures include the PRISM and SCI-SET (condition-specific), SF-36 (generic), and Caregiver Burden Scale and Zarit Burden Interview (caregiver burden). Consideration should be given to using condition-specific and generic measures in combination; the PRISM or SCI-SET combined with SF-36 is recommended.

show abstract

Clinical Assessment of Spasticity in People With Spinal Cord Damage: Recommendations From the Ability Network, an International Initiative

Cited by 17 publications

References 50 publications

Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury

Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury

Studies on Spasticity from an Interventional Perspective

A review and evaluation of patient-reported outcome measures for spasticity in persons with spinal cord damage: Recommendations from the Ability Network – an international initiative

Contact Info

Product

Resources

About